Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat

doi:10.1083/jcb.111.3.1275

This Article

	Full Text (PDF, 915K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Brake, D. A.
	Articles by Biesecker, G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Brake, D. A.
	Articles by Biesecker, G.


Social Bookmarking

	What's this?

ARTICLES

Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat

DA Brake, C Debouck and G Biesecker
Department of Molecular Genetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.

Tat, the transactivation factor of human immunodeficiency virus type 1 (HIV-1), contains the highly conserved tripeptide sequence Arg-Gly-Asp (RGD) that characterizes sites for integrin-mediated cell adhesion. The tat protein was assayed for cell attachment activity by measuring the adhesion of monocytic, T lymphocytic, and skeletal muscle-derived cell lines to tat-coated substratum. All cell lines tested bound to tat in a dose-dependent manner and the tat cell adhesion required the RGD sequence because tat mutants constructed to contain an RGE or KGE tripeptide sequence did not mediate efficient cell adhesion. The tat- mediated cell attachment also required divalent cations and an intact cytoskeleton. In addition, cell adhesion to tat was inhibited in the presence of an RGD-containing peptide GRGDSPK or an anti-tat mAb that recognizes the RGD epitope. These results strongly suggest that cells are bound to tat through an integrin. Interestingly, myoblast cells bound to tat remained round, whereas the same cells attached through an integrin for a matrix protein typically flatten and spread. The role of this RGD-dependent cellular adhesion of tat in HIV-1 infection remains to be determined.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Sui, Z., Sniderhan, L. F., Schifitto, G., Phipps, R. P., Gelbard, H. A., Dewhurst, S., Maggirwar, S. B. (2007). Functional Synergy between CD40 Ligand and HIV-1 Tat Contributes to Inflammation: Implications in HIV Type 1 Dementia. J. Immunol. 178: 3226-3236 [Abstract] [Full Text]
Li, L., Lin, S., Yang, F. (2006). Characterization of an envelope protein (VP110) of White spot syndrome virus. J. Gen. Virol. 87: 1909-1915 [Abstract] [Full Text]
Kittiworakarn, J., Lecoq, A., Moine, G., Thai, R., Lajeunesse, E., Drevet, P., Vidaud, C., Menez, A., Leonetti, M. (2006). HIV-1 Tat Raises an Adjuvant-free Humoral Immune Response Controlled by Its Core Region and Its Ability to Form Cysteine-mediated Oligomers. J. Biol. Chem. 281: 3105-3115 [Abstract] [Full Text]
Urbinati, C., Mitola, S., Tanghetti, E., Kumar, C., Waltenberger, J., Ribatti, D., Presta, M., Rusnati, M. (2005). Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. Arterioscler. Thromb. Vasc. Bio. 25: 2315-2320 [Abstract] [Full Text]
Moreau, E., Belliard, G., Partidos, C. D., Pradezinsky, F., Le Buanec, H., Muller, S., Desgranges, C. (2004). Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides. J. Gen. Virol. 85: 2893-2901 [Abstract] [Full Text]
Wang, F.-Z., Akula, S. M., Sharma-Walia, N., Zeng, L., Chandran, B. (2003). Human Herpesvirus 8 Envelope Glycoprotein B Mediates Cell Adhesion via Its RGD Sequence. J. Virol. 77: 3131-3147 [Abstract] [Full Text]
Tikhonov, I., Ruckwardt, T. J., Hatfield, G. S., Pauza, C. D. (2003). Tat-Neutralizing Antibodies in Vaccinated Macaques. J. Virol. 77: 3157-3166 [Abstract] [Full Text]
Ambrosino, C., Palmieri, C., Puca, A., Trimboli, F., Schiavone, M., Olimpico, F., Ruocco, M. R., di Leva, F., Toriello, M., Quinto, I., Venuta, S., Scala, G. (2002). Physical and Functional Interaction of HIV-1 Tat with E2F-4, a Transcriptional Regulator of Mammalian Cell Cycle. J. Biol. Chem. 277: 31448-31458 [Abstract] [Full Text]
Cota-Gomez, A., Flores, N. C., Cruz, C., Casullo, A., Aw, T. Y., Ichikawa, H., Schaack, J., Scheinman, R., Flores, S. C. (2002). The Human Immunodeficiency Virus-1 Tat Protein Activates Human Umbilical Vein Endothelial Cell E-selectin Expression via an NF-kappa B-dependent Mechanism. J. Biol. Chem. 277: 14390-14399 [Abstract] [Full Text]
Barillari, G., Ensoli, B. (2002). Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma. Clin. Microbiol. Rev. 15: 310-326 [Abstract] [Full Text]
Prakash, O., Tang, Z.-Y., He, Y.-e, Ali, M. S., Coleman, R., Gill, J., Farr, G., Samaniego, F. (2000). Human Kaposi's Sarcoma Cell-Mediated Tumorigenesis in Human Immunodeficiency Type 1 Tat-Expressing Transgenic Mice. JNCI J Natl Cancer Inst 92: 721-728 [Abstract] [Full Text]
Mitola, S., Soldi, R., Zanon, I., Barra, L., Gutierrez, M. I., Berkhout, B., Giacca, M., Bussolino, F. (2000). Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells. J. Virol. 74: 344-353 [Abstract] [Full Text]
Secchiero, P., Zella, D., Capitani, S., Gallo, R. C., Zauli, G. (1999). Extracellular HIV-1 Tat Protein Up-Regulates the Expression of Surface CXC-Chemokine Receptor 4 in Resting CD4+ T Cells. J. Immunol. 162: 2427-2431 [Abstract] [Full Text]
Huang, L., Bosch, I., Hofmann, W., Sodroski, J., Pardee, A. B. (1998). Tat Protein Induces Human Immunodeficiency Virus Type 1�(HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains. J. Virol. 72: 8952-8960 [Abstract] [Full Text]
Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Aluigi, M. G., Proudfoot, A. E.�I., Alouani, S., Wells, T. N.�C., Mariani, G., Rabin, R. L., Farber, J. M., Noonan, D. M. (1998). HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 95: 13153-13158 [Abstract] [Full Text]
Albini, A., Benelli, R., Giunciuglio, D., Cai, T., Mariani, G., Ferrini, S., Noonan, D. M. (1998). Identification of a Novel Domain of HIV Tat Involved in Monocyte Chemotaxis. J. Biol. Chem. 273: 15895-15900 [Abstract] [Full Text]
Gibellini, D., Bassini, A., Pierpaoli, S., Bertolaso, L., Milani, D., Capitani, S., La Placa, M., Zauli, G. (1998). Extracellular HIV-1 Tat Protein Induces the Rapid Ser133 Phosphorylation and Activation of CREB Transcription Factor in Both Jurkat Lymphoblastoid T Cells and Primary Peripheral Blood Mononuclear Cells. J. Immunol. 160: 3891-3898 [Abstract] [Full Text]
Mitola, S., Sozzani, S., Luini, W., Primo, L., Borsatti, A., Weich, H., Bussolino, F. (1997). Tat-Human Immunodeficiency Virus-1 Induces Human Monocyte Chemotaxis by Activation of Vascular Endothelial Growth Factor Receptor-1. Blood 90: 1365-1372 [Abstract] [Full Text]
Li, C. J., Ueda, Y., Shi, B., Borodyansky, L., Huang, L., Li, Y.-Z., Pardee, A. B. (1997). Tat protein induces self-perpetuating permissivity for productive HIV-1�infection. Proc. Natl. Acad. Sci. USA 94: 8116-8120 [Abstract] [Full Text]
Rusnati, M., Coltrini, D., Oreste, P., Zoppetti, G., Albini, A., Noonan, D., di Fagagna, F. d'A., Giacca, M., Presta, M. (1997). Interaction of HIV-1 Tat Protein with Heparin. ROLE OF THE BACKBONE STRUCTURE, SULFATION, AND SIZE. J. Biol. Chem. 272: 11313-11320 [Abstract] [Full Text]
Gibellini, D., Caputo, A., Capitani, S., La Placa, M., Zauli, G. (1997). Upregulation of c-Fos in Activated T Lymphoid and Monocytic Cells by Human Immunodeficiency Virus-1 Tat Protein. Blood 89: 1654-1664 [Abstract] [Full Text]
Channavajjala, L., Eidsath, A, Saxinger, W. (1997). A simple method for measurement of cell-substrate attachment forces: application to HIV-1 Tat. J. Cell Sci. 110: 249-256 [Abstract]
Milani, D., Mazzoni, M., Borgatti, P., Zauli, G., Cantley, L., Capitani, S. (1996). Extracellular Human Immunodeficiency Virus Type-1 Tat Protein Activates Phosphatidylinositol 3-Kinase in PC12 Neuronal Cells. J. Biol. Chem. 271: 22961-22964 [Abstract] [Full Text]